Skip to main content
. 2022 Aug 16;7(5):e00318-22. doi: 10.1128/msphere.00318-22

TABLE 1.

Experimental model organisms used in synthetic community experiments

Species Exptl strain Relative abundance of the genus in clinical samples (%)
Pseudomonas aeruginosa PDO300 (mucoid) PAO1 (wild type) 29.7
Veillonella parvula Clinicala 9.8
Rothia mucilaginosa ATCC 49042b 9.1
Prevotella melaninogenica ATCC 25845b 8.4
Streptococcus mitis ATCC 49456c 7.9
Haemophilus influenza e ATCC 10211 5.8
Staphylococcus aureus SAJE2 5.6
Achromobacter xylosoxidans ATCC 27061 4.8
Neisseria subflava ATCC 49275c 1.8
Burkholderia cenocepacia K56-2 1.1
a

Isolate from Children’s Hospital of Atlanta. Collectively, these organisms represent over 85% of clinical sequence reads across a 77-person CF lung microbiome study (57).

b

Pulmonary source.

c

Oral source. Bold font indicates established CF pathogen (14).